Health
The Indian Pharma Industry – Where to Next?
Alex pointed me to a recent working paper on the Indian pharma industry: The Sectoral System of Innovation of Indian Pharmaceutical Industry by the CDS. Since the Indian patent laws were revised to become TRIPS complaint in 2005, there has been much speculation on how the industry would progress. This paper has some important clues.
The US Pharma Industry
Even as I was writing about problems of the pharmaceutical industry – in the context of R&D for developing world diseases – I come across two broader issues about the US. First, Alex pointed me to Marcia Angell, a Senior Lecturer in Social Medicine at Harvard Medical School. Her book, The Truth About the Drug [...]
The Failure of Pharmaceutical R&D: Policy & Markets (4/4)
This is the conclusion of a 4 part series (Read part 1, part 2, part 3). Global pharmaceutical R&D has failed, and continues to fail, the world’s poor. The reason is simple. Investments in R&D follow potential drug sales. This is the underlying logic of the 10/90 gap, explains why drug development in neglected diseases [...]
The Failure of Pharmaceutical R&D: High Drug Costs (3/4)
In previous posts (part 1-the health gap & part 2-current responses) I pointed out that the basic reason for the failure of pharmaceutical R&D was a lack of markets in the developing world. However, current responses are inadequate to address the gap. As I argue here, there are other systemic problems that inhibit market incentives [...]
The Failure of Pharmaceutical R&D: Current Responses (2/4)
This is part 2 in a 4 part series. Read Part 1. Since the 90/10 gap was first understood, it has been a top priority of international agencies, philanthropists, and governments involved in global healthcare. As a result, several strategies have been deployed.
The Failure of Pharmaceutical R&D: Part 1
The NYTimes is carrying an interesting piece of news – a non-profit organization (NPO) is conducting trials of a long-forgotten medicine to combat black fever in India. This is not a new development but it does highlight the failure of pharmaceutical R&D in satisfying the needs of the developing world. This failure is known as [...]
Categories
Most Emailed
- Financial Inclusion in India: Trends Beyond Microfinance - 34 emails
- A literature review of the impact of microfinance - 25 emails
- India’s Foreign Aid Program - 14 emails
- The Indo-US Nuclear Deal: A Post-Henry Hyde Act Analysis - 12 emails
- Nyama Choma at Olepolos - 9 emails
